Sharon Benzeno, Chief Business Development Officer at Adaptive Biotechnologies Corp (ADPT), sold 1,354 shares at $41.22 ($56K) on 2021-03-15, disclosed to the SEC on 2021-03-17.
Scheduled sale ($56k) by Chief Business Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.22 | 340 | $14K | 24.8% |
| 2 | $41.85 | 1,014 | $42K | 75.2% |
| Total | $41.69 avg | 1,354 | $56K | 100% |
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |